The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

Summary Background The international standard radiotherapy schedule for early breast cancer delivers 50 Gy in 25 fractions of 2·0 Gy over 5 weeks, but there is a long history of non-standard regimens delivering a lower total dose using fewer, larger fractions (hypofractionation). We aimed to test the benefits of radiotherapy schedules using fraction sizes larger than 2·0 Gy in terms of local-regional tumour control, normal tissue responses, quality of life, and economic consequences in women prescribed post-operative radiotherapy. Methods Between 1999 and 2001, 2215 women with early breast cancer (pT1-3a pN0-1 M0) at 23 centres in the UK were randomly assigned after primary surgery to receive 50 Gy in 25 fractions of 2·0 Gy over 5 weeks or 40 Gy in 15 fractions of 2·67 Gy over 3 weeks. Women were eligible for the trial if they were aged over 18 years, did not have an immediate reconstruction, and were available for follow-up. Randomisation method was computer generated and was not blinded. The protocol-specified principal endpoints were local-regional tumour relapse, defined as reappearance of cancer at irradiated sites, late normal tissue effects, and quality of life. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN59368779. Findings 1105 women were assigned to the 50 Gy group and 1110 to the 40 Gy group. After a median follow up of 6·0 years (IQR 5·0–6·2) the rate of local-regional tumour relapse at 5 years was 2·2% (95% CI 1·3–3·1) in the 40 Gy group and 3·3% (95% CI 2·2 to 4·5) in the 50 Gy group, representing an absolute difference of −0·7% (95% CI −1·7% to 0·9%)—ie, the absolute difference in local-regional relapse could be up to 1·7% better and at most 1% worse after 40 Gy than after 50 Gy. Photographic and patient self-assessments indicated lower rates of late adverse effects after 40 Gy than after 50 Gy. Interpretation A radiation schedule delivering 40 Gy in 15 fractions seems to offer rates of local-regional tumour relapse and late adverse effects at least as favourable as the standard schedule of 50 Gy in 25 fractions.

[1]  S M Bentzen,et al.  Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  H D Thames,et al.  Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  S. Powell.  1–41 Fractionation Sensitivity and Dose Response of Late Adverse Effects in the Breast After Radiotherapy for Early Breast Cancer: Long-Term Results of a Randomised Trial , 2006 .

[4]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[5]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D G Altman,et al.  Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.

[7]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[8]  Lambert Zijp,et al.  Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  P. Hoskin,et al.  Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. , 2003, International journal of radiation oncology, biology, physics.

[10]  C. Mcbain,et al.  Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  M. Ritter,et al.  The alpha/beta ratio for prostate cancer: what is it, really? , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Hoskin,et al.  The START trial-measurements in semi-anatomical breast and chest wall phantoms. , 2001, Physics in medicine and biology.

[13]  P. Hoskin,et al.  A survey of radiotherapy quality control practice in the United Kingdom for the START trial. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  P. Hoskin,et al.  Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  T. Whelan,et al.  Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. , 1996, Journal of the National Cancer Institute.

[16]  R. Swindell,et al.  Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  D. Ash,et al.  Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  H D Thames,et al.  Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  M. Brundage,et al.  A shorter fractionation schedule for postlumpectomy breast cancer patients. , 2000, International journal of radiation oncology, biology, physics.

[20]  Anthony Fyles,et al.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. , 2002, Journal of the National Cancer Institute.

[21]  L. Cohen.  Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations. , 1952, The British journal of radiology.

[22]  Y. Kawagoe.  The Treatment of Malignant Disease by Radium and X-Rays Being a Practice of Radiotherapy , 1948, The Indian medical gazette.

[23]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[24]  P. Hoskin,et al.  What is the optimum breast plan: a study based on the START trial plans. , 2006, The British journal of radiology.

[25]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[26]  Melvin L. Griem,et al.  Prescribing, Recording, and Reporting Photon Beam Therapy , 1994 .

[27]  D A Morgan,et al.  The role of biologically effective dose (BED) in clinical oncology. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  A. Rodger.  Fears over radiotherapy fractionation regimens in breast cancer , 1998, BMJ.

[29]  P. Hoskin,et al.  Breast radiotherapy phantom design for the START trial. START trial management group. , 2000, The British journal of radiology.

[30]  M. Peters,et al.  Wedge Resection and Irradiation: An Effective Treatment in Early Breast Cancer , 1967 .

[31]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[32]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[33]  C. Doll,et al.  Late cosmetic results of short fractionation for breast conservation. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Melania Pintilie,et al.  Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[35]  Roger Owen,et al.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[37]  P. Hoskin,et al.  The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  S. Bentzen,et al.  The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  B. Douglas,et al.  Novel fractionation schemes and high linear energy transfer. , 1984, Progress in experimental tumor research.

[40]  A. Luini,et al.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. , 1993, The New England journal of medicine.

[41]  John R Yarnold,et al.  Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. , 2006, The Lancet. Oncology.

[42]  S. Bentzen.  Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed , 2005, Acta oncologica.

[43]  M. Williams,et al.  National survey of radiotherapy fractionation practice in 2003. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[44]  T. Whelan,et al.  Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update , 1996 .

[45]  J. Haviland,et al.  The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). , 2007, Breast.

[46]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[47]  E. Franssen,et al.  Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? , 1999, International journal of radiation oncology, biology, physics.